Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (unaudited)

v3.22.2
Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (unaudited) - USD ($)
$ in Thousands
Total
IPO
Series A Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
IPO
Series B Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
IPO
Common Stock
Common Stock
IPO
Common Stock
License Agreement with Stanford
Additional Paid in Capital
Additional Paid in Capital
IPO
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ (65,408)                 $ 5,183     $ (70,591)
Temporary equity, Beginning balance, Shares at Dec. 31, 2020     30,019,945                    
Temporary equity, Beginning balance at Dec. 31, 2020     $ 55,608                    
Beginning balance at Dec. 31, 2020             10,279,102            
Issuance of redeemable convertible preferred stock for cash     $ 14,997   $ 150,524                
Issuance of redeemable convertible preferred stock for cash, Shares     15,000,000   29,792,487                
Stock-based compensation expense 1,033                 1,033      
Common stock issued upon exercise of options, shares             918,825            
Vesting of early exercised stock options 7                 7      
Reclassification of tranche liability upon settlement     $ 39,403                    
Net loss (19,709)                       (19,709)
Ending balance at Mar. 31, 2021 (84,077)                 6,223     (90,300)
Temporary equity, Ending balance, Shares at Mar. 31, 2021     45,019,945   29,792,487                
Temporary equity, Ending balance at Mar. 31, 2021     $ 110,008   $ 150,524                
Ending balance, Shares at Mar. 31, 2021             11,197,927            
Beginning balance at Dec. 31, 2020 (65,408)                 5,183     (70,591)
Temporary equity, Beginning balance, Shares at Dec. 31, 2020     30,019,945                    
Temporary equity, Beginning balance at Dec. 31, 2020     $ 55,608                    
Beginning balance at Dec. 31, 2020             10,279,102            
Net loss and comprehensive loss $ (37,238)                        
Common stock issued upon exercise of options, shares 922,208                        
Net loss $ (37,238)                        
Ending balance at Jun. 30, 2021 379,184           $ 1     487,012     (107,829)
Ending balance, Shares at Jun. 30, 2021             55,979,002            
Beginning balance at Mar. 31, 2021 (84,077)                 6,223     (90,300)
Temporary equity, Beginning balance, Shares at Mar. 31, 2021     45,019,945   29,792,487                
Temporary equity, Beginning balance at Mar. 31, 2021     $ 110,008   $ 150,524                
Beginning balance at Mar. 31, 2021             11,197,927            
Stock-based compensation expense 2,018                 2,018      
Net loss and comprehensive loss (17,529)                       (17,529)
Common stock shares issued upon early exercise of options $ 21                 21      
Common stock issued upon exercise of options, shares 3,383           3,383            
Issuance of common stock   $ 218,177                 $ 218,177    
Issuance of common stock, Shares               14,000,000 640,861        
Repurchase of common shares in connection with terms of License Agreement with Stanford                 (624,845)        
Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering   $ 260,532           $ 1     $ 260,531    
Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering       (45,019,945)   (29,792,487)              
Temporary equity, Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering       $ (110,008)   $ (150,524)              
Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering, Shares               30,761,676          
Vesting of early exercised stock options $ 42                 42      
Net loss (17,529)                        
Ending balance at Jun. 30, 2021 379,184           $ 1     487,012     (107,829)
Ending balance, Shares at Jun. 30, 2021             55,979,002            
Beginning balance at Dec. 31, 2021 384,050           $ 1     525,400     (141,351)
Beginning balance at Dec. 31, 2021             58,010,823            
Stock-based compensation expense 3,342                 3,342      
Vesting of early exercised stock options 51                 51      
Unrealized loss on investment (309)                     $ (309)  
Net loss (25,835)                       (25,835)
Ending balance at Mar. 31, 2022 361,299           $ 1     528,793   (309) (167,186)
Ending balance, Shares at Mar. 31, 2022             58,010,823            
Beginning balance at Dec. 31, 2021 384,050           $ 1     525,400     (141,351)
Beginning balance at Dec. 31, 2021             58,010,823            
Net loss and comprehensive loss (52,804)                        
Net loss (51,771)                        
Ending balance at Jun. 30, 2022 338,456           $ 1     532,610   (1,033) (193,122)
Ending balance, Shares at Jun. 30, 2022             58,211,192            
Beginning balance at Mar. 31, 2022 361,299           $ 1     528,793   (309) (167,186)
Beginning balance at Mar. 31, 2022             58,010,823            
Stock-based compensation expense 3,360                 3,360      
Net loss and comprehensive loss (26,660)                        
Common stock shares issued upon early exercise of options 13                 13      
Common stock issued upon exercise of options, shares             43,945            
Common stock issued under ESPP, Shares             207,137            
Common stock issued under ESPP 414                 414      
Vesting of early exercised stock options 30                 30      
Repurchase of unvested early exercised stock options, Shares             (50,713)            
Repurchase of unvested early exercised stock options, Value 0                 0      
Unrealized loss on investment (724)                     (724)  
Net loss (25,936)                       (25,936)
Ending balance at Jun. 30, 2022 $ 338,456           $ 1     $ 532,610   $ (1,033) $ (193,122)
Ending balance, Shares at Jun. 30, 2022             58,211,192